vs

Side-by-side financial comparison of ARGENX SE (ARGX) and Polaris Inc. (PII). Click either name above to swap in a different company.

ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $1.7B, roughly 1.5× Polaris Inc.). ARGENX SE runs the higher net margin — 35.5% vs -2.8%, a 38.3% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 8.0%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $-342.5M).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Polaris Inc. is an American automotive manufacturer headquartered in Medina, Minnesota, United States. Polaris was founded in Roseau, Minnesota, where it still has engineering and manufacturing facilities. The company manufactured motorcycles through its Victory Motorcycles subsidiary until January 2017, then produced motorcycles through the Indian Motorcycle subsidiary, which it purchased in April 2011 and announced its divestiture in October 2025. Polaris produced personal watercraft from 1...

ARGX vs PII — Head-to-Head

Bigger by revenue
ARGX
ARGX
1.5× larger
ARGX
$2.5B
$1.7B
PII
Growing faster (revenue YoY)
ARGX
ARGX
+75.2% gap
ARGX
83.2%
8.0%
PII
Higher net margin
ARGX
ARGX
38.3% more per $
ARGX
35.5%
-2.8%
PII
More free cash flow
ARGX
ARGX
$664.9M more FCF
ARGX
$322.4M
$-342.5M
PII

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ARGX
ARGX
PII
PII
Revenue
$2.5B
$1.7B
Net Profit
$877.2M
$-47.2M
Gross Margin
89.5%
20.2%
Operating Margin
28.9%
76.5%
Net Margin
35.5%
-2.8%
Revenue YoY
83.2%
8.0%
Net Profit YoY
1.3%
29.0%
EPS (diluted)
$13.25
$-0.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARGX
ARGX
PII
PII
Q1 26
$1.7B
Q4 25
$2.5B
$1.9B
Q3 25
$1.8B
Q2 25
$1.8B
$1.9B
Q1 25
$1.5B
Q4 24
$1.4B
$1.8B
Q3 24
$1.7B
Q2 24
$901.9M
$2.0B
Net Profit
ARGX
ARGX
PII
PII
Q1 26
$-47.2M
Q4 25
$877.2M
$-303.6M
Q3 25
$-15.8M
Q2 25
$414.8M
$-79.3M
Q1 25
$-66.8M
Q4 24
$865.6M
$10.6M
Q3 24
$27.7M
Q2 24
$-32.5M
$68.7M
Gross Margin
ARGX
ARGX
PII
PII
Q1 26
20.2%
Q4 25
89.5%
20.0%
Q3 25
20.7%
Q2 25
89.2%
19.4%
Q1 25
16.0%
Q4 24
90.2%
20.4%
Q3 24
20.6%
Q2 24
89.4%
21.6%
Operating Margin
ARGX
ARGX
PII
PII
Q1 26
76.5%
Q4 25
28.9%
-16.7%
Q3 25
1.1%
Q2 25
19.2%
-0.7%
Q1 25
-2.4%
Q4 24
8.7%
3.7%
Q3 24
3.8%
Q2 24
-15.4%
6.1%
Net Margin
ARGX
ARGX
PII
PII
Q1 26
-2.8%
Q4 25
35.5%
-15.8%
Q3 25
-0.9%
Q2 25
23.4%
-4.3%
Q1 25
-4.3%
Q4 24
64.1%
0.6%
Q3 24
1.6%
Q2 24
-3.6%
3.5%
EPS (diluted)
ARGX
ARGX
PII
PII
Q1 26
$-0.83
Q4 25
$13.25
$-5.34
Q3 25
$-0.28
Q2 25
$6.32
$-1.39
Q1 25
$-1.17
Q4 24
$13.33
$0.18
Q3 24
$0.49
Q2 24
$-0.55
$1.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARGX
ARGX
PII
PII
Cash + ST InvestmentsLiquidity on hand
$3.5B
$282.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$7.3B
$750.4M
Total Assets
$8.7B
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARGX
ARGX
PII
PII
Q1 26
$282.0M
Q4 25
$3.5B
$138.0M
Q3 25
$335.5M
Q2 25
$2.1B
$324.3M
Q1 25
$291.7M
Q4 24
$1.5B
$287.8M
Q3 24
$291.3M
Q2 24
$1.4B
$322.7M
Total Debt
ARGX
ARGX
PII
PII
Q1 26
Q4 25
$1.5B
Q3 25
$1.3B
Q2 25
$1.4B
Q1 25
$1.6B
Q4 24
$1.6B
Q3 24
$1.7B
Q2 24
$11.0M
$2.1B
Stockholders' Equity
ARGX
ARGX
PII
PII
Q1 26
$750.4M
Q4 25
$7.3B
$828.4M
Q3 25
$1.1B
Q2 25
$6.1B
$1.2B
Q1 25
$1.2B
Q4 24
$5.5B
$1.3B
Q3 24
$1.3B
Q2 24
$4.3B
$1.3B
Total Assets
ARGX
ARGX
PII
PII
Q1 26
$5.2B
Q4 25
$8.7B
$4.9B
Q3 25
$5.3B
Q2 25
$7.2B
$5.4B
Q1 25
$5.5B
Q4 24
$6.2B
$5.5B
Q3 24
$5.6B
Q2 24
$4.8B
$5.7B
Debt / Equity
ARGX
ARGX
PII
PII
Q1 26
Q4 25
1.82×
Q3 25
1.13×
Q2 25
1.17×
Q1 25
1.32×
Q4 24
1.27×
Q3 24
1.29×
Q2 24
0.00×
1.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARGX
ARGX
PII
PII
Operating Cash FlowLast quarter
$323.3M
Free Cash FlowOCF − Capex
$322.4M
$-342.5M
FCF MarginFCF / Revenue
13.0%
-20.6%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.37×
TTM Free Cash FlowTrailing 4 quarters
$594.5M
$168.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARGX
ARGX
PII
PII
Q1 26
Q4 25
$323.3M
$178.7M
Q3 25
$158.8M
Q2 25
$361.8M
$320.3M
Q1 25
$83.2M
Q4 24
$41.9M
$206.3M
Q3 24
$21.0M
Q2 24
$-124.7M
$146.3M
Free Cash Flow
ARGX
ARGX
PII
PII
Q1 26
$-342.5M
Q4 25
$322.4M
$114.0M
Q3 25
$116.7M
Q2 25
$356.6M
$279.8M
Q1 25
$47.6M
Q4 24
$40.9M
$137.3M
Q3 24
$-32.4M
Q2 24
$-125.5M
$79.1M
FCF Margin
ARGX
ARGX
PII
PII
Q1 26
-20.6%
Q4 25
13.0%
5.9%
Q3 25
6.3%
Q2 25
20.1%
15.1%
Q1 25
3.1%
Q4 24
3.0%
7.8%
Q3 24
-1.9%
Q2 24
-13.9%
4.0%
Capex Intensity
ARGX
ARGX
PII
PII
Q1 26
Q4 25
0.0%
3.4%
Q3 25
2.3%
Q2 25
0.3%
2.2%
Q1 25
2.3%
Q4 24
0.1%
3.9%
Q3 24
3.1%
Q2 24
0.1%
3.4%
Cash Conversion
ARGX
ARGX
PII
PII
Q1 26
Q4 25
0.37×
Q3 25
Q2 25
0.87×
Q1 25
Q4 24
0.05×
19.46×
Q3 24
0.76×
Q2 24
2.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons